Capricor Therapeutics Inc Stock
Capricor Therapeutics Inc gained 0.930% compared to yesterday.
Our community identified positive and negative aspects for Capricor Therapeutics Inc stock for the coming years. 0 users see the criterium "Return on equity" as a plus for the Capricor Therapeutics Inc stock. On the other hand our users think that "Return on equity" could be a problem in the future.
Pros and Cons of Capricor Therapeutics Inc in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Capricor Therapeutics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Capricor Therapeutics Inc | 0.930% | 2.138% | 16.216% | 162.195% | 17.349% | 736.111% | 829.012% |
| Sangamo Therapeutics Inc. | -29.780% | -28.034% | -47.665% | -76.534% | -53.545% | -88.964% | -98.322% |
| Evolus Inc | -0.440% | 13.384% | 20.053% | -55.100% | -17.615% | -41.307% | -41.688% |
| Corbus Pharmaceuticals Holding Inc. | -2.290% | 1.805% | 21.389% | 23.099% | 24.857% | 6696.267% | -79.570% |
News
Here's Why This Biotechnology Skyrocketed by 439% in December
Capricor Therapeutics (NASDAQ: CAPR) stock rose an incredible 439.4% in December, according to data provided by S&P Global Market Intelligence. The move followed the company's announcement of
